REGENXBIO Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2015 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: REGENXBIO Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2015 to Q2 2024.
REGENXBIO Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $9.44M, a 10.2% decline year-over-year.
REGENXBIO Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $37.6M, a 9.11% decline year-over-year.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.3M, a 1.28% decline from 2022.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2022 was $40.8M, a 5.1% increase from 2021.
REGENXBIO Inc. annual Share-based Payment Arrangement, Expense for 2021 was $38.8M, a 21.5% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$37.6M	$9.44M	-$1.07M	-10.2%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$38.7M	$9.6M	-$1.6M	-14.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$40.3M	$8.34M	-$1.07M	-11.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-27
Q3 2023	$41.3M	$10.2M	-$26K	-0.25%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$41.4M	$10.5M	+$169K	+1.64%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-01
Q1 2023	$41.2M	$11.2M	+$406K	+3.76%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$40.8M	$9.41M	+$246K	+2.69%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$40.5M	$10.2M	+$511K	+5.25%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	$40M	$10.3M	+$343K	+3.43%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-02
Q1 2022	$39.7M	$10.8M	+$880K	+8.87%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-03
Q4 2021	$38.8M	$9.16M	+$1.58M	+20.9%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-27
Q3 2021	$37.2M	$9.73M	+$1.7M	+21.1%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$35.5M	$9.99M	+$1.68M	+20.2%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-03
Q1 2021	$33.9M	$9.92M	+$1.9M	+23.7%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$31.9M	$7.58M	+$706K	+10.3%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-28
Q3 2020	$31.2M	$8.04M	+$873K	+12.2%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-02
Q2 2020	$30.4M	$8.32M	+$1.22M	+17.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$29.2M	$8.02M	+$2.3M	+40.2%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$26.9M	$6.88M	+$1.99M	+40.7%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-01
Q3 2019	$24.9M	$7.16M	+$2.68M	+59.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-04
Q2 2019	$22.2M	$7.1M	+$3.12M	+78.3%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$19.1M	$5.72M	+$2.43M	+73.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$16.6M	$4.89M	+$2.09M	+74.7%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018	$14.6M	$4.48M	+$1.75M	+64%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	$12.8M	$3.98M	+$1.5M	+60.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018	$11.3M	$3.29M	+$700K	+27%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-07
Q4 2017	$10.6M	$2.8M	+$797K	+39.9%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-26
Q3 2017	$9.81M	$2.73M	+$905K	+49.5%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	$8.9M	$2.48M	+$827K	+49.9%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017	$8.08M	$2.59M	+$1.05M	+67.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	$7.03M	$2M			Oct 1, 2016	Dec 31, 2016	10-K	2019-02-27
Q3 2016		$1.83M	+$480K	+35.6%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016		$1.66M			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016		$1.55M			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q3 2015		$1.35M			Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.